U.S., March 6 -- ClinicalTrials.gov registry received information related to the study (NCT07453082) titled 'A Prospective Study to Evaluate miRNA371 and Outcomes in Patients With Newly Diagnosed Germ Cell Tumors' on March 25, 2024.
Brief Summary: This is a observational study aimed at evaluating miRNA 371a-3p (miRNA 371) as a specific marker for presence or absence of clinically detectable viable germ cell malignancy.
Study Start Date: July 01, 2021
Study Type: OBSERVATIONAL
Condition:
Testicular Germ Cell Tumor
Recruitment Status: RECRUITING
Sponsor: Fondazione del Piemonte per l'Oncologia
Published by HT Digital Content Services with permission from Health Daily Digest....